Cancer Profiling Market Analysis, Trend, Size, Share, and Forecast 2017 – 2026

Posted on 2018-02-01 by Mark Hub in Healthcare // 0 Comments

Fact.MR

Rockville, US, 2018-Feb-01 — /EPR Network/ —Cancer profiling market is witnessing significant growth due to the growing number of cancer cases, increasing use of biomarkers, and the rise in funding for research on cancer. Key players in the cancer profiling market are focusing on new technically advanced product launches, increasing investment in research and development, and partnerships to set footprints globally. Companies are also focusing on developing advanced techniques to identify genomic alteration in order to help in selecting correct therapy in cancer treatment. This Fact.MR report analyzes the expansion of global cancer profiling market till date, and provides key insights on the growth of the market during the forecast period, 2017-2026.

Request For Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=358

The report offers an overview of the global cancer profiling market. This comprises an introduction to the market, along with a standard definition of the product – cancer profiling. In this section, market value and year-over-year growth is offered to the readers. Year-over-year growth provides readers with a broader view of growth patterns over the forecast period.

The report’s succeeding section focuses on drivers, restraints and key trends from macroeconomic, demand, and supply perspectives. Impact analysis of weighted average model-based growth drivers is contained in the report for better provision of decision-making insights to clients.

In order to offer readers with up-to-date information about the latest advancements in the global cancer profiling market, the report provides updates about market opportunities, which can benefit leading manufacturers of cancer profiling. With continuous evolution of the healthcare sector, keeping a record of latest developments and trends is fundamental for cancer profiling manufacturers to formulate key business strategies. Detailed insights about raw material sourcing, supply chain, regulatory approvals, pricing analysis, list of distributors, and cost structure are provided in this section.

Forecast Highlights on Global Cancer Profiling Market

North America is expected to remain dominant in the global cancer profiling market during the forecast period 2017-2026. Changing lifestyle with increasing consumption of alcohol, smoking is leading to the increasing number of people suffering from cancer. Moreover, increasing investment in research and development activities are driving the demand for cancer profiling in the region.
Asia Pacific Excluding Japan (APEJ) and Europe are also witnessing significant growth in the cancer profiling. Increasing incidence of lung cancer and prostate cancer in central, eastern, and southern Europe is driving the demand for cancer profiling. Meanwhile, breast cancer is the most diagnosed cancer among women in China and India.
Next-generation sequencing is expected to be the highly-preferred technique in cancer profiling market. By the end of 2026, next-generation sequencing is estimated to reach 62,000 million revenue.
Pharmaceutical and biotech companies are expected to be the largest users of cancer profiling. Pharmaceutical and biotech companies are estimated to surpass US$ 52,400 million revenue by the end of 2026.
Diagnosis is expected to witness significant growth in the global cancer profiling market. By the end of 2026, diagnosis is estimated to surpass US$ 40,000 million in terms of revenue.

Cancer Profiling to Find Largest Application in Diagnosis

Cancer profiling is used for research, prognosis, personalized medicine, biomarker discovery. However, cancer profiling is likely to find the largest application in diagnosis. Gaining considerable growth, diagnosis is anticipated to create an absolute dollar opportunity of over US$ 32,200 million between 2017 and 2026. Cancer profiling plays an important role in diagnosis, as it helps physicians in understanding cancer tumor and identifying type of cancer. It also helps in taking appropriate decisions, avoiding ‘over-treatment’ of cancer patients.

Browse Full Report with TOC @https://www.factmr.com/report/358/cancer-profiling-market

Competition Tracking

The report also profiles companies that are expected to remain active in the expansion of global cancer profiling market through 2026, which include Agendia, Genomic Health Inc., Oxford Gene Technology Ltd., NeoGenomics Laboratories, RiboMed Biotechnologies Inc., BioTheranostics, Proteome Sciences PLC, Illumina, Inc. (U.S.), GenScript, Caris Life Sciences, and Roche Holdings.

Check Discount @ https://www.factmr.com/connectus/sample?flag=D&rep_id=358

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Matched content

Editor’s pick